In a groundbreaking nationwide study published in BMC Cancer, researchers have unveiled critical new insights into the real-world epidemiology, management,...

Abexinostat, a novel pan-histone deacetylase inhibitor, is emerging as a promising therapeutic agent for patients with relapsed or refractory B...

In a groundbreaking study poised to transform our understanding of pituitary neuroendocrine tumors (PitNETs), researchers have deployed cutting-edge single-cell and...

A landmark advancement in the treatment of newly diagnosed multiple myeloma patients has emerged from the recently presented ADVANCE clinical...

A groundbreaking study led by researchers at the Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School...

In the evolving landscape of adolescent and young adult (AYA) oncology care, a groundbreaking study out of the University of...

A groundbreaking study led by researchers at the University of Cincinnati Cancer Center has unveiled novel insights into the intricate...

An innovative clinical trial spearheaded by researchers at Northwestern Medicine has revealed unexpected potential for a drug already approved to...

Advances in data collection over the past decade have granted unprecedented access to detailed patient information, often encompassing entire genomic...

In a groundbreaking study that promises to reshape how physicians manage long-term care for childhood cancer survivors, researchers at St....